Popular on Rezul
- Family Office Real Estate Institute Announces Exclusive Investment Forum - 122
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software - 121
- Felician Sisters of North America Announce Partnership with City of Livonia - 120
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY - 120
- Baltimore Author Crafts Space Opera Where Human Questions Outshine Galactic Scale - 102
- Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees
- OpsVeda Announces Launch of TariffSight, the World's First Comprehensive Platform to Address Tariff-Driven Challenges
- How to Fast-Track Your Way to the Top with The Code
- Charleston, SC - ACSEC offers Rain Barrels Through Annual Program
- Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned
Similar on Rezul
- CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
- Pregis Expands its Curbside-Recyclable Paper Packaging Portfolio with White EasyPack GeoTerra
- Advanced Dental Techniques Recognized as a Top Family Dentist for 2024
- Solomon Eye Physicians & Surgeons announces appointment of Ann Reiling as Chief Operations Officer
- APA Faces Outrage: Child Deaths and a $329 Billion Mental Health Failure
- Koplon Implant & Family Dentistry Receives National Recognition as One of the Best Dental Implant Practices in the U.S
- $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- The ROS1ders Announces Recipients of 2024 ROS1+ Cancer Innovation Awards
Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
Rezul News/10703040
BOWIE, Md. - Rezul -- Solomon Eye Physicians and Surgeons is proud to announce the promotion of Dr. Nancy Draskovic to Clinical Director of Ocular Surface Disease, a new leadership role created to advance the organization's commitment to clinical excellence and innovation in patient care.
Dr. Draskovic joined Solomon Eye in 2017 and has consistently demonstrated exceptional expertise in the diagnosis and management of complex ocular conditions. Her collaborative approach, dedication to patient outcomes, and passion for education have made her an invaluable asset to both patients and colleagues alike.
In this new role, Dr. Draskovic will lead the clinical strategy for the Ocular Disease division, supporting best-in-class protocols, mentoring clinical staff, and driving continued advancement in treatment options for conditions such as dry eye, glaucoma, macular degeneration, and diabetic eye disease.
More on Rezul News
"Dr. Draskovic's promotion reflects both her outstanding clinical leadership and our continued focus on delivering top-tier, patient-centered care," said Dr. Jonathan Solomon, Medical Director at Solomon Eye. "She brings the perfect balance of experience, innovation, and compassion to this role."
Dr. Draskovic holds her Doctor of Optometry from The New England College of Optometry with residency training at the Baltimore VA Medical Center focused on ocular disease. She is an active member of the American Academy of Optometry and frequently lectures on advancements in disease management and interdisciplinary care.
"I'm honored to take on this position and work alongside a team so deeply committed to improving the lives of our patients," said Dr. Draskovic. "Together, we'll continue to raise the standard of care in our community."
For more information about Solomon Eye Physicians and Surgeons and its full range of services, visit www.solomoneye.com.
Dr. Draskovic joined Solomon Eye in 2017 and has consistently demonstrated exceptional expertise in the diagnosis and management of complex ocular conditions. Her collaborative approach, dedication to patient outcomes, and passion for education have made her an invaluable asset to both patients and colleagues alike.
In this new role, Dr. Draskovic will lead the clinical strategy for the Ocular Disease division, supporting best-in-class protocols, mentoring clinical staff, and driving continued advancement in treatment options for conditions such as dry eye, glaucoma, macular degeneration, and diabetic eye disease.
More on Rezul News
- Business Funding Assist Significantly Expands Funding Solutions, Empowering Businesses Across the U.S. and Canada
- Leadership Expert and Author Adam Holbrook Launches Breakthrough Book: Character Evolution
- Premium Domain Name "Feedri.com" Now Available for Acquisition After $8,500 Offer
- 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
- American Property Group Announces $2.1M Sale of Freestanding Restaurant on US 41 in Sarasota
"Dr. Draskovic's promotion reflects both her outstanding clinical leadership and our continued focus on delivering top-tier, patient-centered care," said Dr. Jonathan Solomon, Medical Director at Solomon Eye. "She brings the perfect balance of experience, innovation, and compassion to this role."
Dr. Draskovic holds her Doctor of Optometry from The New England College of Optometry with residency training at the Baltimore VA Medical Center focused on ocular disease. She is an active member of the American Academy of Optometry and frequently lectures on advancements in disease management and interdisciplinary care.
"I'm honored to take on this position and work alongside a team so deeply committed to improving the lives of our patients," said Dr. Draskovic. "Together, we'll continue to raise the standard of care in our community."
For more information about Solomon Eye Physicians and Surgeons and its full range of services, visit www.solomoneye.com.
Source: Solomon Eye
0 Comments
Latest on Rezul News
- How Does Google Crawl Websites?
- A-One Janitorial Joins Urban Land Institute to Advance Sustainable Facility Practices
- Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJellâ„¢ collagen peptide formulation
- Garneau Electric Enhances Home Safety with Expert Electrical Panel Upgrades in Windham
- Las Vegas Realtor Nancy Ruiz Earns Certified Luxury Home Marketing Specialistâ„¢ Designation
- Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement
- CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Diversified Properties Expands Property Management Division
- $10 Million Plan to Acquire Successful Remote Lottery Platform: Expanding Global Footprint into Live Entertainment: Lottery.com (Stock Symbol: LTRY)
- Assent Launches Carbon Border Adjustment Mechanism Solution to Help Manufacturers Meet Regulatory Requirements
- Q1 2025 Revenue Soars 92% to $1.13M on Strategic Acquisitions, Organic Growth & Breakthroughs in AI Drones & Quantum Tech: ZenaTech Stock Symbol: ZENA
- Savista Retreat Announces Monthly Yoga, Wellness & Experiential Retreats in Jaipur
- Robert Tsigler Selected by NADC as Top 1% Attorney in the U.S. for 2025
- **Award-Winning Dystopian Book Series Hitting Too Close to Home**
- BLDG Collective Expands Transformative Remodeling Services in Boulder, Colorado
- Store Space Opens New Climate-Controlled Facility Storage In Chesterfield, MI
- Neoware Unveils Strategic Transformation as a Specialist "Data to Intelligence" Partner
- Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
- Pregis Expands its Curbside-Recyclable Paper Packaging Portfolio with White EasyPack GeoTerra
- Advanced Dental Techniques Recognized as a Top Family Dentist for 2024